Magle Chemoswed
Xbrane clears the FDA, BioInvent seeks 430 Mkr and Genmab keeps surging – the Nordic Pulse | 2026:44
Analytics
Zealand wins in obesity, Genmab hits first-line DLBCL and Oncopeptides crosses the blood-brain barrier – the Nordic Pulse | 2026:41
Egetis wins FDA approval, Indices retreat across the board – the Nordic Pulse | 2026:40
A quarter of billion-euro licences, a Novo comeback and a flat Nordic index – the State of Nordic BioPharma | 2026:Q3
Analytics
Nanexa lands billion-euro Novo deal, Nordic index slides nearly three per cent – the Nordic Pulse | 2026:39
AstraZeneca’s hat-trick, a broad sell-off and Alzinova funds its Alzheimer’s push – the Nordic Pulse | 2026:37
Magle Chemoswed licensierar ut stamcellsteknologi till tidigare vd:n
Magle Chemoswed byter styrelseordförande
Nyhetssvepet måndag 9 juni
Nyhetssvepet tisdag 27 maj
Nyhetssvepet måndag 28 april
Magle PharmaCept
Nyhetssvepet fredag 25 april
Iconovo
